BACKGROUND AND OBJECTIVE: Minimal clinically important difference (MCID) values of 4 and 6 points have been proposed for interpreting meaningful change in Multiple Sclerosis Walking Scale-12 (MSWS-12) scores. This study examined the validity of those MCID values based on capturing corresponding changes in other walking outcomes in persons with multiple sclerosis (MS). METHODS: On 2 occasions separated by 6 months, 82 persons with MS completed the MSWS-12, timed 25-ft walk (T25FW), 6-min walk (6MW), and gait analysis, and then wore an accelerometer over a 7-day period. We generated change scores for the MSWS-12 and formed groups of stable, worsened, and improved perceived walking based on both 4- and 6-point changes. The groups were compared for corresponding changes in other walking measures over time using mixed-model ANOVAs. RESULTS: The mixed-model ANOVAs did not identify statistically significant group-by-time interactions on the T25FW (p = 0.98 and p = 0.67), the 6MW (p = 0.89 and p = 0.72), gait (p = 0.54 and p = 0.21), or accelerometry (p = 0.40 and p = 0.68) for MCID values of 4- or 6-point changes in MSWS-12 scores. CONCLUSIONS: We did not confirm that MCID values of 4 and 6 points for the MSWS-12 correspond with changes in performance, gait, and free-living assessments of walking in MS.
BACKGROUND AND OBJECTIVE: Minimal clinically important difference (MCID) values of 4 and 6 points have been proposed for interpreting meaningful change in Multiple Sclerosis Walking Scale-12 (MSWS-12) scores. This study examined the validity of those MCID values based on capturing corresponding changes in other walking outcomes in persons with multiple sclerosis (MS). METHODS: On 2 occasions separated by 6 months, 82 persons with MS completed the MSWS-12, timed 25-ft walk (T25FW), 6-min walk (6MW), and gait analysis, and then wore an accelerometer over a 7-day period. We generated change scores for the MSWS-12 and formed groups of stable, worsened, and improved perceived walking based on both 4- and 6-point changes. The groups were compared for corresponding changes in other walking measures over time using mixed-model ANOVAs. RESULTS: The mixed-model ANOVAs did not identify statistically significant group-by-time interactions on the T25FW (p = 0.98 and p = 0.67), the 6MW (p = 0.89 and p = 0.72), gait (p = 0.54 and p = 0.21), or accelerometry (p = 0.40 and p = 0.68) for MCID values of 4- or 6-point changes in MSWS-12 scores. CONCLUSIONS: We did not confirm that MCID values of 4 and 6 points for the MSWS-12 correspond with changes in performance, gait, and free-living assessments of walking in MS.
Authors: V J Block; A Lizée; E Crabtree-Hartman; C J Bevan; J S Graves; R Bove; A J Green; B Nourbakhsh; M Tremblay; P-A Gourraud; M Y Ng; M J Pletcher; J E Olgin; G M Marcus; D D Allen; B A C Cree; J M Gelfand Journal: J Neurol Date: 2016-11-28 Impact factor: 4.849
Authors: Myla D Goldman; Melanie D Ward; Robert W Motl; David E Jones; John H Pula; Diego Cadavid Journal: Mult Scler Date: 2016-12-07 Impact factor: 6.312
Authors: Jennifer L Moore; Kirsten Potter; Kathleen Blankshain; Sandra L Kaplan; Linda C OʼDwyer; Jane E Sullivan Journal: J Neurol Phys Ther Date: 2018-07 Impact factor: 3.649
Authors: Matthew M Engelhard; Karen M Schmidt; Casey E Engel; J Nicholas Brenton; Stephen D Patek; Myla D Goldman Journal: Qual Life Res Date: 2016-06-24 Impact factor: 4.147
Authors: Valerie A J Block; Erica Pitsch; Peggy Tahir; Bruce A C Cree; Diane D Allen; Jeffrey M Gelfand Journal: PLoS One Date: 2016-04-28 Impact factor: 3.240
Authors: Navina N Nasseri; Eghbal Ghezelbash; Yuyang Zhai; Stefan Patra; Karin Riemann-Lorenz; Christoph Heesen; Anne C Rahn; Jan-Patrick Stellmann Journal: PeerJ Date: 2020-06-23 Impact factor: 2.984
Authors: Valerie J Block; Chao Zhao; Jill A Hollenbach; Jeffrey E Olgin; Gregory M Marcus; Mark J Pletcher; Roland Henry; Jeffrey M Gelfand; Bruce Ac Cree Journal: Mult Scler J Exp Transl Clin Date: 2019-11-21